The tide of A-share repurchase is rising again! According to Hithink Royalflush Information Network Co.Ltd(300033) data, since the beginning of this year, as of 5:00 p.m. on March 14, a total of 75 listed companies have announced repurchase plans for a shares, of which 14 listed companies are in the stage of board plan, 51 listed companies are in the process of repurchase, 9 listed companies have completed share repurchase, and Shenzhen Mindray Bio-Medical Electronics Co.Ltd(300760) has cancelled the repurchased shares.
Hu Qimu, chief researcher of Sinosteel Economic Research Institute, told the Securities Daily that recently, affected by regional conflicts, global commodity price fluctuations have intensified, and the stock market has pulled back under the expectation of rising upstream costs and tight supply. However, in the medium and long term, the fundamentals of China’s economy have not changed, and the correction of the stock market more reflects the risk aversion of the market.
multiple tracks “Mao”
start repurchase
“Yaomao” Jiangsu Hengrui Medicine Co.Ltd(600276) launched a large-scale repurchase. On the evening of March 13, Jiangsu Hengrui Medicine Co.Ltd(600276) announced that the total amount of funds the company intends to use for repurchase is no less than 600 million yuan and no more than 1.2 billion yuan. Based on the calculation of the maximum repurchase capital of RMB 1.2 billion and the maximum repurchase price of RMB 60.22/share, the number of shares repurchased is expected to be about 199269 million, accounting for about 0.31% of the current total share capital of the company. The implementation period of share repurchase shall not exceed 12 months from the date when the board of directors of the company deliberates and approves the repurchase plan.
“The share repurchase price is no more than 60.22 yuan / share. The company’s shares will be repurchased from the secondary market by means of centralized bidding transaction. The source of funds for repurchasing shares is Jiangsu Hengrui Medicine Co.Ltd(600276) own funds. The shares repurchased this time will be used for employee stock ownership plan or equity incentive.” Jiangsu Hengrui Medicine Co.Ltd(600276) announcement said.
On the afternoon of March 14, Winning Health Technology Group Co.Ltd(300253) announced that the company plans to use its own funds to repurchase its shares through centralized bidding. The total amount of funds to be repurchased is no less than 100 million yuan and no more than 150 million yuan, and the repurchase price is no more than 15 yuan / share (inclusive); Purpose of Share Repurchase: it is used for the implementation of employee stock ownership plan, equity incentive or the conversion of convertible corporate bonds issued by Listed Companies in the future.
It is worth mentioning that since this year, in addition to Jiangsu Hengrui Medicine Co.Ltd(600276) , Winning Health Technology Group Co.Ltd(300253) and Winning Health Technology Group Co.Ltd(300253) , several track “Mao” have announced repurchase plans.
Midea Group Co.Ltd(000333) 3 announced on March 12 that in combination with the company’s current financial and operating conditions, it is determined that the total amount of funds for this share repurchase shall not exceed 5 billion yuan and not be less than 2.5 billion yuan. The source of the company’s own funds is the company’s own funds. All the shares repurchased will be used to implement the company’s equity incentive plan and / or employee stock ownership plan.
On March 9, S.F.Holding Co.Ltd(002352) announced that based on confidence in future development prospects and high recognition of its own value, the company began to implement share repurchase on March 3, 2022. As of March 9, 2022, the company has repurchased 103266 million shares of the company through centralized bidding through the special securities account for share repurchase. The repurchase fund is about 565 million yuan (excluding transaction costs), the number of shares repurchased accounts for 0.21% of the company’s total share capital, and the average transaction price is 54.72 yuan / share. For purposes, S.F.Holding Co.Ltd(002352) the shares repurchased this time will be used to implement employee incentive.
Repurchase amount of Companies
minimum over 100 million yuan
Hithink Royalflush Information Network Co.Ltd(300033) data show that as of March 14, the minimum amount of share repurchase plans issued by 29 listed companies exceeded 100 million yuan. Among them, the minimum capital amount of Midea Group Co.Ltd(000333) , Hengli Petrochemical Co.Ltd(600346) , S.F.Holding Co.Ltd(002352) 3 listed companies to repurchase shares exceeds 1 billion yuan. In addition, the minimum amount of Jiangsu Hengrui Medicine Co.Ltd(600276) , Yonyou Network Technology Co.Ltd(600588) , Zhejiang Century Huatong Group Co.Ltd(002602) and other listed companies to repurchase shares exceeds 100 million yuan.
With the fluctuation of the secondary market, many listed companies have repurchased their own shares with real money and silver.
Opple Lighting Co.Ltd(603515) 3 on the evening of March 14, the announcement on the progress of share repurchase by means of centralized bidding transaction was issued, which said that as of March 14, 2022, the company had repurchased 431700 shares of the company through centralized bidding transaction, accounting for about 0.06% of the total share capital of the company, and the total amount of funds paid was about 7.839 million yuan (excluding transaction costs), The lowest transaction price is 17.86 yuan / share and the highest transaction price is 18.2 yuan / share. The repurchase implemented by the company complies with the established share repurchase plan.
Ningbo Peacebird Fashion Co.Ltd(603877) announced that as of March 14, 2022, the company had repurchased 809800 shares through centralized bidding, accounting for 0.17% of the total share capital of the company. The highest transaction price was 22.4 yuan / share, the lowest transaction price was 21.5 yuan / share, and the total accumulated payment was 17.863 million yuan (excluding transaction costs).
“On the one hand, the repurchase of listed companies can boost market confidence. On the other hand, from the purpose of repurchasing shares, some are used for incentives, which is conducive to deeply bind the core team, stimulate the initiative of the team, and drive the growth of the company’s performance and the improvement of the stock price.” An investor who declined to be named told the Securities Daily.